Mednow Financial Statements From 2010 to 2024
| MDNWF Stock | USD 0.02 0.00 0.00% |
Check Mednow financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mednow's main balance sheet or income statement drivers, such as , as well as many indicators such as . Mednow financial statements analysis is a perfect complement when working with Mednow Valuation or Volatility modules.
Mednow |
Mednow Inc Company Return On Asset Analysis
Mednow's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mednow Return On Asset | -0.55 |
Most of Mednow's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mednow Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Mednow Inc has a Return On Asset of -0.5537. This is 93.67% lower than that of the Healthcare sector and significantly lower than that of the Health Information Services industry. The return on asset for all United States stocks is notably higher than that of the company.
Mednow Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mednow's current stock value. Our valuation model uses many indicators to compare Mednow value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mednow competition to find correlations between indicators driving Mednow's intrinsic value. More Info.Mednow Inc is regarded second in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mednow's earnings, one of the primary drivers of an investment's value.About Mednow Financial Statements
Mednow stakeholders use historical fundamental indicators, such as Mednow's revenue or net income, to determine how well the company is positioned to perform in the future. Although Mednow investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mednow's assets and liabilities are reflected in the revenues and expenses on Mednow's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mednow Inc. Please read more on our technical analysis and fundamental analysis pages.
Mednow Inc., a healthcare company, develops and operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and the delivery of virtual care, telemedicine services, and doctor home visits in Canada. The company was incorporated in 2018 and is headquartered in Vancouver, Canada. Mednow is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Mednow Pink Sheet
Mednow financial ratios help investors to determine whether Mednow Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mednow with respect to the benefits of owning Mednow security.